Molecular investigation of a multisource outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates.

PubWeight™: 2.66‹?› | Rank: Top 1%

🔗 View Article (PMID 9392588)

Published in Am J Trop Med Hyg on November 01, 1997

Authors

L L Rodriguez1, G O Maupin, T G Ksiazek, P E Rollin, A S Khan, T F Schwarz, R S Lofts, J F Smith, A M Noor, C J Peters, S T Nichol

Author Affiliations

1: Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30329-4018, USA.

Articles citing this

Crimean-Congo hemorrhagic fever virus genomics and global diversity. J Virol (2006) 2.39

Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus. J Virol (2002) 1.68

Genetic detection and isolation of crimean-congo hemorrhagic fever virus, Kosovo, Yugoslavia. Emerg Infect Dis (2002) 1.68

Crimean-Congo hemorrhagic fever in Kosovo. J Clin Microbiol (2002) 1.64

Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis (2004) 1.57

Crimean-Congo hemorrhagic fever in Bulgaria. Emerg Infect Dis (2004) 1.54

Immunofluorescence technique using HeLa cells expressing recombinant nucleoprotein for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus. J Clin Microbiol (2002) 1.37

Recombinant nucleoprotein-based enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus. J Clin Microbiol (2002) 1.35

Crimean-Congo hemorrhagic fever virus: genetic analysis and tick survey in Turkey. J Clin Microbiol (2006) 1.21

Genetic characterization of the M RNA segment of Crimean Congo hemorrhagic fever virus strains, China. Emerg Infect Dis (2002) 1.13

Imported Crimean-Congo hemorrhagic fever cases in Istanbul. BMC Infect Dis (2007) 1.04

Crimean-Congo hemorrhagic fever, southwestern Bulgaria. Emerg Infect Dis (2009) 1.03

Genetic analysis of Crimean-Congo hemorrhagic fever virus in Russia. J Clin Microbiol (2003) 0.97

Multiple Crimean-Congo hemorrhagic fever virus strains are associated with disease outbreaks in Sudan, 2008-2009. PLoS Negl Trop Dis (2011) 0.97

First international external quality assessment of molecular detection of Crimean-Congo hemorrhagic fever virus. PLoS Negl Trop Dis (2012) 0.96

Epidemiology and phylogenetic analysis of crimean-congo hemorrhagic fever viruses in xinjiang, china. J Clin Microbiol (2009) 0.95

A nosocomial transmission of crimean-congo hemorrhagic fever to an attending physician in North Kordufan, Sudan. Virol J (2011) 0.95

Re-emergence of Crimean-Congo hemorrhagic fever virus in Central Africa. PLoS Negl Trop Dis (2011) 0.94

Crimean-Congo hemorrhagic fever in man, Republic of Georgia, 2009. Emerg Infect Dis (2010) 0.94

Low-density macroarray for rapid detection and identification of Crimean-Congo hemorrhagic fever virus. J Clin Microbiol (2009) 0.87

Molecular epidemiology of Crimean-Congo hemorrhagic fever virus in Kosovo. PLoS Negl Trop Dis (2014) 0.85

A seroepidemiological survey of Crimean Congo hemorrhagic fever among cattle in North Kordufan State, Sudan. Virol J (2013) 0.84

Diagnostic assays for Crimean-Congo hemorrhagic fever. Emerg Infect Dis (2012) 0.84

Prevalence of Crimean-Congo hemorrhagic fever virus in healthy population, livestock and ticks in Kosovo. PLoS One (2014) 0.84

Seroepidemiological Studies of Crimean-Congo Hemorrhagic Fever Virus in Domestic and Wild Animals. PLoS Negl Trop Dis (2016) 0.83

Animal models of tick-borne hemorrhagic Fever viruses. Pathogens (2013) 0.81

Genetic Diversity of Crimean Congo Hemorrhagic Fever Virus Strains from Iran. J Arthropod Borne Dis (2016) 0.80

A case of crimean-congo hemorrhagic Fever in oman. Oman Med J (2013) 0.80

Genetic analysis and epidemiology of Crimean Congo Hemorrhagic fever viruses in Baluchistan province of Pakistan. BMC Infect Dis (2013) 0.80

A patient with Crimean-Congo hemorrhagic fever serologically diagnosed by recombinant nucleoprotein-based antibody detection systems. Clin Diagn Lab Immunol (2003) 0.79

Assessment of Recombination in the S-segment Genome of Crimean-Congo Hemorrhagic Fever Virus in Iran. J Arthropod Borne Dis (2015) 0.79

Species distribution and detection of Crimean Congo Hemorrhagic Fever Virus (CCHFV) in field-collected ticks in Ankara Province, Central Anatolia, Turkey. Exp Appl Acarol (2011) 0.78

Sero-epidemiological survey of Crimean-Congo hemorrhagic fever virus in Tunisia. Parasite (2016) 0.75

Study of the genetic variability of Crimean-Congo hemorrhagic fever virus in Central Asia. Dokl Biochem Biophys (2004) 0.75

Infection prevention and control practice for Crimean-Congo hemorrhagic fever-A multi-center cross-sectional survey in Eurasia. PLoS One (2017) 0.75

Articles by these authors

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet (2009) 13.51

Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39

Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science (1993) 9.11

Development of a preventive vaccine for Ebola virus infection in primates. Nature (2000) 8.32

Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med (1994) 7.61

The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 7.39

The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A (1996) 7.02

Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science (1999) 6.94

Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 6.72

Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA (2002) 6.59

Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science (1998) 5.83

Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis (1999) 5.59

Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol (1995) 5.30

Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet (1999) 5.14

Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis (1994) 4.97

Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.96

The accuracy of human population maps for public health application. Trop Med Int Health (2005) 4.64

Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.28

Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis (1997) 4.03

ELISA for the detection of antibodies to Ebola viruses. J Infect Dis (1999) 3.92

Zika virus, a cause of fever in Central Java, Indonesia. Trans R Soc Trop Med Hyg (1981) 3.72

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology (1997) 3.62

Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J Infect Dis (1999) 3.62

Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet (1990) 3.55

Predictors of the quality of health worker treatment practices for uncomplicated malaria at government health facilities in Kenya. Int J Epidemiol (2004) 3.51

Identification of a human population infected with simian foamy viruses. Nat Med (1998) 3.47

Patterns of association with host and habitat: antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States. Am J Trop Med Hyg (1997) 3.46

Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol (1999) 3.44

Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis (2001) 3.42

Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 3.36

Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis (1999) 3.34

Assessing the accuracy of satellite derived global and national urban maps in Kenya. Remote Sens Environ (2005) 3.33

Immunization for Ebola virus infection. Nat Med (1998) 3.27

Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet (1999) 3.24

Reye's syndrome in the United States from 1981 through 1997. N Engl J Med (1999) 3.20

Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J Virol (1985) 3.06

Genetic diversity among Lassa virus strains. J Virol (2000) 3.00

Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol (1998) 2.99

Measurement of antibodies to Machupo virus by the indirect fluorescent technique. Proc Soc Exp Biol Med (1973) 2.97

A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States. J Infect Dis (1995) 2.95

Feline oncornavirus-associated cell membrane antigen: evidence for an immunologically crossreactive feline sarcoma virus-coded protein. Proc Natl Acad Sci U S A (1977) 2.93

Amblyomma americanum: a potential vector of human ehrlichiosis. Am J Trop Med Hyg (1993) 2.84

Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology (1997) 2.78

Distribution, diversity, and host specificity of Bartonella in rodents from the Southeastern United States. Am J Trop Med Hyg (1997) 2.77

Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis (1999) 2.76

Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol (2006) 2.73

Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol (1985) 2.71

Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol (1992) 2.69

Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch Virol Suppl (1996) 2.69

Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis (1996) 2.64

Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology (2000) 2.63

Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: possible agent of a Lyme disease-like illness. J Infect Dis (1996) 2.63